FMP
PNK
NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio.
0.0065 USD
-0.0015 (-23.08%)
Valuation Date:
May 3, 2024 2:32 PM
Share Price on Valuation Date
$0.01
Stock Beta
1.458
Shares Outstanding
27673600